ACURX PHARMACEUTICALS INC's ticker is ACXP and the CUSIP is 00510M104. A total of 15 filers reported holding ACURX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,150 | -43.4% | 10,100 | 0.0% | 0.00% | – |
| Q2 2023 | $26,765 | -23.4% | 10,100 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $34,946 | -13.1% | 10,100 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $40,198 | +34.0% | 10,100 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $30,000 | -21.1% | 10,100 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $38,000 | +15.2% | 10,100 | 0.0% | 0.00% | – |
| Q1 2022 | $33,000 | -69.4% | 10,100 | -59.8% | 0.00% | -100.0% |
| Q4 2021 | $108,000 | +10.2% | 25,100 | +31.4% | 0.00% | 0.0% |
| Q3 2021 | $98,000 | +53.1% | 19,100 | +91.0% | 0.00% | 0.0% |
| Q2 2021 | $64,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Draper Asset Management, LLC | 266,025 | $1,058,780 | 1.47% |
| ARMISTICE CAPITAL, LLC | 880,000 | $3,502,400 | 0.06% |
| Semmax Financial Advisors Inc. | 5,879 | $24 | 0.01% |
| Belpointe Asset Management LLC | 3,000 | $11,940 | 0.00% |
| TD Waterhouse Canada Inc. | 18,656 | $77,422 | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 10,100 | $40,198 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 77,283 | $307 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 29,096 | $116 | 0.00% |
| BlackRock Inc. | 15,639 | $62,243 | 0.00% |